Results 231 to 240 of about 277,103 (274)

Biomarker and Surrogate Endpoints

American Journal of Therapeutics, 2003
openaire   +3 more sources

FDA validation of surrogate endpoints in oncology: 2005–2022

Journal of Cancer Policy, 2022
Vinay Prasad, Alyson Haslam, Anushka Walia   +2 more
exaly  

Surrogate Endpoint

2003
Shu Zhang, Edward Pun
openaire   +1 more source

Surrogate Endpoint

2023
openaire   +1 more source

Surrogate endpoints in clinical trials: Definition and operational criteria

Statistics in Medicine, 1989
R L Prentice
exaly  

Surrogate Endpoints

2019
Seper Ekhtiari, Ryan P. Coughlin, Nicole Simunovic, Olufemi R. Ayeni   +3 more
openaire   +1 more source

Statistical evaluation of surrogate endpoints with examples from cancer clinical trials

Biometrical Journal, 2016
Koji Oba, Xavier Paoletti, Marc Buyse
exaly  

Surrogate Endpoint

2008
Stuart G. Baker, Barnett S. Kramer
openaire   +1 more source

Surrogate endpoints in clinical trials: Cardiovascular diseases

Statistics in Medicine, 1989
Jeffrey L Probstfield
exaly  

Surrogate endpoints: A basis for a rational approach

European Journal of Clinical Pharmacology, 1992
J P Boissel, J P Collet
exaly